Mapping breast cancer lineage in radiation and immunotherapy using the REMAP mouse
REMAP, a lineage-tracing mouse model coupling inducible CRISPR recording with the MMTV-PyMT model of HR+ breast cancer, reveals heritable clonal programs governing metastasis and response to combined radiation and anti-PD1 immunotherapy.